Download Free The Marginal Cost Of Mortality Risk Reduction Book in PDF and EPUB Free Download. You can read online The Marginal Cost Of Mortality Risk Reduction and write the review.

We provide the first evidence that spatial variation in all-cause mortality risk is capitalized into US housing prices. Using a hedonic framework, we recover the annual implicit cost of a 0.1 percentage-point reduction in mortality risk among older Americans and find that this figure is both relatively low and decreasing in age, from $1,346 for a 67 year old to $246 for an 87 year old. These estimates are one-fifth of the size of comparable estimates found in the labor market, suggesting that the housing market provides an alternative, substantially cheaper channel to reducing mortality risk.
We provide the first evidence that spatial variation in all-cause mortality risk is capitalized into US housing prices. Using a hedonic framework, we recover the annual implicit cost of a 0.1 percentage-point reduction in mortality risk among older Americans and find that this figure is both relatively low and decreasing in age, from $1,346 for a 67 year old to $246 for an 87 year old. These estimates are one-fifth of the size of comparable estimates found in the labor market, suggesting that the housing market provides an alternative, substantially cheaper channel to reducing mortality risk.
In light of recent evidence on the relationship of ozone to mortality and questions about its implications for benefit analysis, the Environmental Protection Agency asked the National Research Council to establish a committee of experts to evaluate independently the contributions of recent epidemiologic studies to understanding the size of the ozone-mortality effect in the context of benefit analysis. The committee was also asked to assess methods for estimating how much a reduction in short-term exposure to ozone would reduce premature deaths, to assess methods for estimating associated increases in life expectancy, and to assess methods for estimating the monetary value of the reduced risk of premature death and increased life expectancy in the context of health-benefits analysis. Estimating Mortality Risk Reduction and Economic Benefits from Controlling Ozone Air Pollution details the committee's findings and posits several recommendations to address these issues.
Regulations to promote health and safety may be costly relative to the expected health and safety benefits, and may actually have negative effects on health and safety. These negative effects, or costs, may be due to reduced private spending on health and safety, moral hazard, or the creation of new risks. This volume considers the use of costs--benefit analysis, risk--risk analysis, and health--health analysis to determine the mortality cost associated with regulatory expenditures.
Abstract: The value of mortality risk reduction is an important component of the benefits of environmental policies. In recent years, the number, scope, and quality of valuation studies have increased dramatically. Revealed-preference studies of wage compensation for occupational risks, on which analysts have primarily relied, have benefited from improved data and statistical methods. Stated-preference research has improved methodologically and expanded dramatically. Studies are now available for several health conditions associated with environmental causes and researchers have explored many issues concerning the validity of the estimates. With the growing numbers of both types of studies, several meta-analyses have become available that provide insight into the results of both methods. Challenges remain, including better understanding of the persistently smaller estimates from stated-preference than from wage-differential studies and of how valuation depends on the individual's age, health status, and characteristics of the illnesses most frequently associated with environmental causes
Two internet-based surveys were conducted with adults aged 35 to 84 - 885 respondents in the United States and 641 respondents in Canada - to estimate willingness to pay (WTP) for reducing mortality risks through out-of-pocket costs for health-care programs. All respondents were asked a series of choice questions followed by a payment-card question. Causes of death included cancer and heart attack. Levels of annual mortality-risk reduction were 1, 2, and 5 in 10,000. Converted to values of statistical life, results were in the range of $4-5 million (2002 U.S. dollars) for the choice-question results for a 2-in-10,000 annual risk reduction for illness-related mortality. U.S. and Canadian results were similar. The payment-card results were about 50% lower than the choice-question results. WTP to reduce mortality risk was essentially the same for cancer and heart attack. The results showed WTP weakly increasing with age, and no evidence of lower WTP for older adults versus middle-aged adults.